Cargando…
Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis
INTRODUCTION: The objective was to investigate the potential implication of the IL18 gene promoter polymorphisms in the susceptibility to giant-cell arteritis (GCA). METHODS: In total, 212 patients diagnosed with biopsy-proven GCA were included in this study. DNA from patients and matched controls w...
Autores principales: | Palomino-Morales, Rogelio J, Vazquez-Rodriguez, Tomas R, Torres, Orlando, Morado, Inmaculada C, Castañeda, Santos, Miranda-Filloy, Jose A, Callejas-Rubio, Jose L, Fernandez-Gutierrez, Benjamin, Gonzalez-Gay, Miguel A, Martin, Javier |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888200/ https://www.ncbi.nlm.nih.gov/pubmed/20331879 http://dx.doi.org/10.1186/ar2962 |
Ejemplares similares
-
Incidence of biopsy-proven giant cell arteritis (GCA) in South Australia 2014–2020
por: Ninan, Jem, et al.
Publicado: (2023) -
Anterior ischemic optic neuropathy due to biopsy-proven giant cell arteritis in Thai patients
por: Attaseth, Taweevat, et al.
Publicado: (2015) -
Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis()
por: Callejas Rubio, José Luis, et al.
Publicado: (2022) -
No Association between FCγR3B Copy Number Variation and Susceptibility to Biopsy-Proven Giant Cell Arteritis
por: Dunstan, Emma, et al.
Publicado: (2013) -
Giant cell arteritis presenting as bilateral anterior ischemic optic neuropathy: a biopsy-proven case report in Chinese patient
por: Tian, Guohong, et al.
Publicado: (2018)